NO20055144L - Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. - Google Patents

Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Info

Publication number
NO20055144L
NO20055144L NO20055144A NO20055144A NO20055144L NO 20055144 L NO20055144 L NO 20055144L NO 20055144 A NO20055144 A NO 20055144A NO 20055144 A NO20055144 A NO 20055144A NO 20055144 L NO20055144 L NO 20055144L
Authority
NO
Norway
Prior art keywords
cattle
treatment
parasitic infections
microbial
animals
Prior art date
Application number
NO20055144A
Other languages
English (en)
Norwegian (no)
Inventor
Dale E Shuster
David G Sawutz
Kanwal J Varma
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of NO20055144L publication Critical patent/NO20055144L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20055144A 2003-04-03 2005-11-02 Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. NO20055144L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46012603P 2003-04-03 2003-04-03
PCT/US2004/010143 WO2004089355A2 (en) 2003-04-03 2004-04-01 Compositions for treating microbial and parasitic infections in cattle and other animals

Publications (1)

Publication Number Publication Date
NO20055144L true NO20055144L (no) 2005-11-02

Family

ID=33159732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055144A NO20055144L (no) 2003-04-03 2005-11-02 Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Country Status (22)

Country Link
US (1) US20040198704A1 (es)
EP (1) EP1608356A2 (es)
JP (1) JP2006522147A (es)
KR (1) KR20060021821A (es)
CN (1) CN1767822A (es)
AR (1) AR043824A1 (es)
AU (1) AU2004227997A1 (es)
BR (1) BRPI0419273A (es)
CA (1) CA2519380A1 (es)
CL (1) CL2004000710A1 (es)
EC (1) ECSP056074A (es)
HK (1) HK1080366A1 (es)
MX (1) MXPA05010693A (es)
NO (1) NO20055144L (es)
NZ (1) NZ542379A (es)
PE (1) PE20050099A1 (es)
PL (1) PL378820A1 (es)
RU (1) RU2359667C2 (es)
TW (1) TW200503682A (es)
UA (1) UA82359C2 (es)
WO (1) WO2004089355A2 (es)
ZA (1) ZA200507857B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
JP4750804B2 (ja) * 2005-02-24 2011-08-17 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト カプセル製剤
CA2672795A1 (en) 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
ES2693696T3 (es) * 2007-11-26 2018-12-13 Merial, Inc. Sistemas de disolventes para formulaciones de unción dorsal continua para combatir parásitos
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
CA2732017A1 (en) 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
KR101473979B1 (ko) * 2013-01-18 2014-12-26 한국썸벧(주) 마보플록사신을 포함하는 약제학적 조성물
RU2641962C2 (ru) * 2013-07-03 2018-01-23 С.П. Ветеринариа, С.А. Инъецируемая ветеринарная композиция
EP3023092A1 (en) * 2014-11-20 2016-05-25 Ceva Sante Animale Eprinomectin parenteral compositions
RU2649809C2 (ru) * 2015-03-03 2018-04-04 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Жидкая гомогенная фаза для трансдермальных фармацевтических композиций
CN105079000B (zh) * 2015-09-22 2018-07-06 佛山市南海东方澳龙制药有限公司 一种组合物及其应用、制剂
CN105796488A (zh) * 2016-03-23 2016-07-27 张先碧 一种氟苯尼考溶液制剂及其制备方法
US9943387B2 (en) 2016-06-29 2018-04-17 International Business Machines Corporation Unmanned aerial vehicle-based system for livestock parasite amelioration
KR102647267B1 (ko) * 2021-06-29 2024-03-18 대한뉴팜(주) 툴라스로마이신과 톨페남산의 복합 주사제 제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
JP4104463B2 (ja) * 2001-04-27 2008-06-18 ファイザー・プロダクツ・インク ４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法
US20030068339A1 (en) * 2001-10-02 2003-04-10 Phoenix Scientific, Inc. Veterinary florfenicol formulation that is syringeable under cold weather conditions
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives
AR044437A1 (es) * 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino

Also Published As

Publication number Publication date
HK1080366A1 (zh) 2006-04-28
RU2359667C2 (ru) 2009-06-27
WO2004089355A2 (en) 2004-10-21
CL2004000710A1 (es) 2005-05-27
CA2519380A1 (en) 2004-10-21
TW200503682A (en) 2005-02-01
NZ542379A (en) 2009-01-31
WO2004089355A3 (en) 2005-01-20
PL378820A1 (pl) 2006-05-29
KR20060021821A (ko) 2006-03-08
AU2004227997A1 (en) 2004-10-21
ZA200507857B (en) 2007-04-25
MXPA05010693A (es) 2005-12-12
WO2004089355A8 (en) 2005-11-03
PE20050099A1 (es) 2005-02-28
AR043824A1 (es) 2005-08-17
UA82359C2 (uk) 2008-04-10
RU2005133875A (ru) 2006-03-20
ECSP056074A (es) 2006-03-01
JP2006522147A (ja) 2006-09-28
US20040198704A1 (en) 2004-10-07
EP1608356A2 (en) 2005-12-28
BRPI0419273A (pt) 2008-07-15
CN1767822A (zh) 2006-05-03

Similar Documents

Publication Publication Date Title
NO20055144L (no) Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
MY135791A (en) Compositions and method for treating infection in cattle and swine
NO20052306L (no) Dispergerbare farmasoytiske blandinger.
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
BRPI0416796A (pt) compostos orgánicos
BR0313148A (pt) Formulações de liberação controlada compreendendo lamotrigina
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
AR048718A1 (es) Uso de formulaciones de meloxicam en medicina veterinaria
CY1107480T1 (el) Χρηση aivlosin για την θepαπευτικη αγωγη και προληψη λοιμωξεων lawsonia σε χοιρους
ATE453646T1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
ITFI20030058A1 (it) Formulazioni farmaceutiche contenenti tiazolidinedioni
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
CY1114480T1 (el) Συνθεσεις που περιλαμβανουν διαχωρισμενο αγωνιστη υποδοχεα γλυκοκορτικοειδους για τη θεραπεια ή τον ελεγχο φλεγμονης προσθιου τμηματος
BRPI0416376A (pt) composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes
BRPI0407368A (pt) tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
AU2001228513A1 (en) Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant
WO2006012146A3 (en) Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
WO2011009771A3 (en) Immunogenic and therapeutic compositions for streptococcus suis
EA200401523A1 (ru) Способы применения и композиции для диагностики и лечения инфекционного заболевания
WO2004098636A3 (en) Vaccinating against infectious diseases using proteosomes
AU2001279693A1 (en) Anthelmintic agents for preventing parasitic infections in humans and animals iii
ATE521336T1 (de) Zusammensetzungen zur tierärztlichen behandlung von mastitis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application